论文部分内容阅读
目的:观察痰热清注射液联合头孢他啶治疗慢性阻塞性肺疾病急性加重期的临床疗效及不良反应。方法:46例临床确诊为慢性阻塞性肺病的患者随机分为两组。治疗组23例,使用痰热清联合头孢他啶治疗。对照组23例单用头孢他啶治疗。结果:治疗组23例经治疗后总有效率91.30%,对照组23例经治疗后总有效率78.26%,治疗组的总有效率与对照组比较,经统计学分析P<0.05,差异有统计学意义。结论:痰热清联合头孢他啶治疗慢性阻塞性肺疾病有良好的临床疗效。
Objective: To observe the clinical efficacy and adverse reactions of Tanreqing Injection and ceftazidime in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: 46 patients with clinically diagnosed chronic obstructive pulmonary disease were randomly divided into two groups. Treatment group 23 cases, the use of Tanreqing combined ceftazidime treatment. The control group of 23 patients treated with ceftazidime alone. Results: In the treatment group, the total effective rate was 91.30% in 23 cases and 23.2% in control group after treatment. The total effective rate in the treatment group was statistically significant (P <0.05), the difference was statistically significant Significance of learning. Conclusion: Tanreqing combined with ceftazidime in the treatment of chronic obstructive pulmonary disease have a good clinical effect.